Figure 6.
Dynamic variations of CTC molecular profile in still living patients at T1 and T2 evaluation with respect to clinical outcomes and therapeutic response (SD: stable disease, PD: progression disease).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.